Tey HL, Cao T, Nattkemper LA, Tan VW, Pramono ZA, Yosipovitch G. Pathophysiology of pruritus in primary localized cutaneous amyloidosis. Br J Dermatol. 2016 Jun. 174 (6):1345-50. [QxMD MEDLINE Link].
Weyers W, Weyers I, Bonczkowitz M, Diaz-Cascajo C, Schill WB. Lichen amyloidosus: a consequence of scratching. J Am Acad Dermatol. 1997 Dec. 37(6):923-8. [QxMD MEDLINE Link].
Yasir M, Mulji NJ, Kasi A. Multiple endocrine neoplasias type 2. StatPearls [Internet]. 2020 Jan. [QxMD MEDLINE Link]. [Full Text].
Malhotra R, Boro H, Shamim SA, Khadgawat R. Multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis. BMJ Case Rep. 2020 Aug 26. 13 (8):e238423. [QxMD MEDLINE Link]. [Full Text].
Stratakis CA. Hereditary syndromes predisposing to endocrine tumors and their skin manifestations. Rev Endocr Metab Disord. 2016 Sep. 17 (3):381-388. [QxMD MEDLINE Link]. [Full Text].
Maddison B, Namazi MR, Samuel LS, et al. Unexpected diminished innervation of epidermis and dermoepidermal junction in lichen amyloidosus. Br J Dermatol. 2008 Aug. 159(2):403-6. [QxMD MEDLINE Link].
Weidner T, Illing T, Elsner P. Primary Localized Cutaneous Amyloidosis: A Systematic Treatment Review. Am J Clin Dermatol. 2017 Oct. 18(5):629-542. [QxMD MEDLINE Link].
Eanes ED, Glenner GG. X-ray diffraction studies on amyloid filaments. J Histochem Cytochem. 1968 Nov. 16(11):673-7. [QxMD MEDLINE Link].
Chapman JR, Liu A, Yi SS, et al. Proteomic analysis shows that the main constituent of subepidermal localised cutaneous amyloidosis is not galectin-7. Amyloid. 2020 Sep 1. 1-7. [QxMD MEDLINE Link].
Apaydin R, Gurbuz Y, Bayramgurler D, Muezzinoglu B, Bilen N. Cytokeratin expression in lichen amyloidosus and macular amyloidosis. J Eur Acad Dermatol Venereol. 2004 May. 18(3):305-9. [QxMD MEDLINE Link].
Lu P, Wu FF, Rong ZL, et al. Clinical and genetic features of Chinese patients with lichen and macular primary localized cutaneous amyloidosis. Clin Exp Dermatol. 2019 Jun. 44 (4):e110-17. [QxMD MEDLINE Link].
Tanaka A, Arita K, Lai-Cheong JE, Palisson F, Hide M, McGrath JA. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol. 2009 Dec. 161(6):1217-24. [QxMD MEDLINE Link].
Lin MW, Lee DD, Liu TT, et al. Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis. Eur J Hum Genet. 2010 Jan. 18 (1):26-32. [QxMD MEDLINE Link].
Ladizinski B, Lee KC. Lichen amyloidosis. CMAJ. 2014 Apr 15. 186 (7):532. [QxMD MEDLINE Link]. [Full Text].
Errichetti E, Stinco G. Dermoscopy in General Dermatology: A Practical Overview. Dermatol Ther (Heidelb). 2016 Dec. 6 (4):471-507. [QxMD MEDLINE Link]. [Full Text].
Frolich M, Enk A, Diepgen TL, Weisshaar E. Successful treatment of therapy-resistant pruritus in lichen amyloidosis with menthol. Acta Derm Venereol. 2009. 89(5):524-6. [QxMD MEDLINE Link].
Castanedo-Cazares JP, Lepe V, Moncada B. Lichen amyloidosis improved by 0.1% topical tacrolimus. Dermatology. 2002. 205(4):420-1. [QxMD MEDLINE Link].
Hsieh SD, Yamamoto R, Saito K, et al. Amyloidosis presented with whitening and loss of hair which improved after dimethylsulfoxide (DMSO) treatment. Jpn J Med. 1987 Aug. 26(3):393-5. [QxMD MEDLINE Link].
Lim KB, Tan SH, Tan KT. Lack of effect of dimethyl sulphoxide (DMSO) on amyloid deposits in lichen amyloidosis. Br J Dermatol. 1988 Sep. 119(3):409-10. [QxMD MEDLINE Link].
Ozkaya-Bayazit E, Kavak A, Gungor H, Ozarmagan G. Intermittent use of topical dimethyl sulfoxide in macular and papular amyloidosis. Int J Dermatol. 1998 Dec. 37(12):949-54. [QxMD MEDLINE Link].
Pandhi R, Kaur I, Kumar B. Lack of effect of dimethylsulphoxide in cutaneous amyloidosis. J Dermatolog Treat. 2002 Mar. 13(1):11-4. [QxMD MEDLINE Link].
Choi JY, Sippe J, Lee S. Acitretin for lichen amyloidosus. Australas J Dermatol. 2008 May. 49(2):109-13. [QxMD MEDLINE Link].
Carlesimo M, Narcisi A, Orsini D, Mari E, Di Russo P, Arcese A, et al. A case of lichen amyloidosus treated with acitretin. Clin Ter. 2011 Mar-Apr. 162(2):e59-61. [QxMD MEDLINE Link].
Ma H, Su X, Zhu G, Yin S, Lu C, Lai W. Primary localized cutaneous amyloidosis with lichen and poikiloderma-like lesions and an excellent response to systemic acitretin. An Bras Dermatol. 2016 Sep-Oct. 91 (5):661-663. [QxMD MEDLINE Link]. [Full Text].
Parsi K, Kossard S. Thermosensitive lichen amyloidosis. Int J Dermatol. 2004 Dec. 43(12):925-8. [QxMD MEDLINE Link].
Terao M, Nishida K, Murota H, Katayama I. Clinical effect of tocoretinate on lichen and macular amyloidosis. J Dermatol. 2011 Feb. 38(2):179-84. [QxMD MEDLINE Link].
Koh WS, Oh EH, Kim JE, Ro YS. Alitretinoin treatment of lichen amyloidosis. Dermatol Ther. 2017 Sep 14. [Epub ahead of print]. [QxMD MEDLINE Link].
Yew YW, Tey HL. Itch in familial lichen amyloidosis: effective treatment with amitriptyline in two cases. Dermatol Ther. 2014 Jan-Feb. 27 (1):12-5. [QxMD MEDLINE Link].
Sawamura D, Sato-Matsumura KC, Shibaki A, Akiyama M, Kikuchi T, Shimizu H. A case of lichen amyloidosis treated with pulsed dye laser. J Eur Acad Dermatol Venereol. 2005 Mar. 19(2):262-3. [QxMD MEDLINE Link].
Aoki M, Kawana S. Lichen amyloidosis of the auricular concha: successful treatment with electrodesiccation. J Dermatol. 2009 Feb. 36(2):116-7. [QxMD MEDLINE Link].
Esmat SM, Fawzi MM, Gawdat HI, Ali HS, Sayed SS. Efficacy of different modes of fractional CO2 laser in the treatment of primary cutaneous amyloidosis: A randomized clinical trial. Lasers Surg Med. 2015 Jul. 47 (5):388-95. [QxMD MEDLINE Link].
Norisugi O, Yamakoshi T, Shimizu T. Successful treatment of lichen amyloidosis using a CO2 surgical laser. Dermatol Ther. 2014 Mar-Apr. 27 (2):71-3. [QxMD MEDLINE Link].
Mehrotra K, Dewan R, Kumar JV, Dewan A. Primary cutaneous amyloidosis: a clinical, histopathological and immunofluorescence study. J Clin Diagn Res. 2017 Aug. 11 (8):WC01-5. [QxMD MEDLINE Link].